Correlation Between Nucleus Software and Mangalam Drugs

Can any of the company-specific risk be diversified away by investing in both Nucleus Software and Mangalam Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nucleus Software and Mangalam Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nucleus Software Exports and Mangalam Drugs And, you can compare the effects of market volatilities on Nucleus Software and Mangalam Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nucleus Software with a short position of Mangalam Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nucleus Software and Mangalam Drugs.

Diversification Opportunities for Nucleus Software and Mangalam Drugs

0.52

Correlation Coefficient

Nucleus Software  Mangalam Drugs

Very weak diversification

The 3 months correlation between Nucleus and Mangalam is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Nucleus Software Exports and Mangalam Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangalam Drugs And and Nucleus Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nucleus Software Exports are associated (or correlated) with Mangalam Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangalam Drugs And has no effect on the direction of Nucleus Software i.e., Nucleus Software and Mangalam Drugs go up and down completely randomly.

Pair Corralation between Nucleus Software and Mangalam Drugs

Assuming the 90 days trading horizon Nucleus Software Exports is expected to under-perform the Mangalam Drugs. In addition to that, Nucleus Software is 1.09 times more volatile than Mangalam Drugs And. It trades about -0.13 of its total potential returns per unit of risk. Mangalam Drugs And is currently generating about -0.13 per unit of volatility. If you would invest  12,213  in Mangalam Drugs And on November 29, 2024 and sell it today you would lose (2,244) from holding Mangalam Drugs And or give up 18.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Nucleus Software Exports  vs.  Mangalam Drugs And

Nucleus Software Exports

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nucleus Software Exports has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Mangalam Drugs And

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Nucleus Software and Mangalam Drugs

The main advantage of trading using opposite Nucleus Software and Mangalam Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nucleus Software position performs unexpectedly, Mangalam Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangalam Drugs will offset losses from the drop in Mangalam Drugs' long position.

The idea behind Nucleus Software Exports and Mangalam Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.